Isolation of human metapneumovirus (HMPV) from clinical specimens is currently inefficient because of the lack of a cell culture system in which a distinct cytopathic effect (CPE) occurs. The cell lines LLC-MK2, Vero and Vero E6 are used for isolation of HMPV; however, the CPE in these cell lines is subtle and usually requires a long observation period and sometimes blind passages. Thus, a cell line in which an early and distinct CPE occurs following HMPV inoculation is highly desired by clinical virology laboratories. In this study, it was demonstrated that, in the human malignant melanoma cell line MNT-1, obvious syncytium formation occurs shortly after inoculation with HMPV-positive clinical specimens. In addition, the growth and efficiency of isolation of HMPV were greater using MNT-1 than using any other conventional cell line. Addition of this cell line to our routine viral isolation system for clinical specimens markedly enhanced isolation frequency, allowing isolationbased surveillance. MNT-1 has the potential to facilitate clinical and epidemiological studies of HMPV.
bronchiolitis and pneumonia, particularly in infants of low birth weight, immunocompromised patients, and older persons (11) (12) (13) . HMPV epidemics reportedly mainly occur during winter and spring in temperate climates (2, 3, 7, [13] [14] [15] [16] [17] [18] [19] ; however, infections can occur throughout the year (16, 17, 20) .
Isolation of HMPV has proven difficult because CPEs on most laboratory cell lines are subtle and require long incubation times. Thus, detection of viral genes by PCR is used as an alternative in many clinical laboratories. Accordingly, many recent studies on HMPV infections are based on genetic amplification (20) (21) (22) (23) (24) . While sensitive, false-positive reactions frequently occur during gene amplification, these being attributable to primer non-specificity or accidental contamination by small amounts of viral material. Furthermore, there is the issue of detecting additional pathogens, which sometimes creates confusion in identifying the true causative agent of the disease (25) (26) (27) (28) (29) . Isolation of specific causative pathogens from clinical specimens has been considered to be the gold standard for diagnosis of infectious diseases (25) and also contributes to further advances in clinical and epidemiological virology. Viruses can be isolated using cell culture systems with characteristic CPEs in response to inoculation with clinical specimens. Cell lines from Rhesus monkey kidney (LLC-MK2) (3, 16, (30) (31) (32) (33) (34) (35) (36) , tertiary monkey kidney (tMK) (2, 37), and African green monkey kidney (Vero and Vero E6) (7, 16, 17, 38) have conventionally been used for HMPV isolation; however, the CPEs observed in these cell lines are subtle. Moreover, HMPV grows slowly and often requires several blind passages before the CPE becomes apparent (2, 3, 16, [31] [32] [33] 36) . Therefore, cell lines exhibiting a more sensitive and rapid CPE are needed for efficient HMPV isolation.
We have been using a microplate system consisting of multiple cell lines, including the human embryonic fibroblast line HFL-III, human laryngeal carcinoma line HEp-2, Vero or Vero E6, Madin-Darby canine kidney line MDCK, human malignant melanoma cell line HMV-II, and LLC-MK2, to isolate various viruses from large numbers of clinical specimens (39, 40) . We have previously, reported the utility of the human malignant melanoma cell line MNT-1 for isolation of HPIVs (41) . Since we adopted this line for HPIV isolation in October 2013, we have discovered that MNT-1 cells can also support the growth of HMPV. In our microplate system, MNT-1 exhibits a characteristic CPE and has unexpectedly resulted in more frequent HMPV isolation than achieved previously using the aforementioned cell lines. In this report, we demonstrate the usefulness of MNT-1 cells for HMPV isolation.
MATERIALS AND METHODS

Ethical considerations
All experimental procedures were approved by the Ethics Committee of Sendai Medical Center.
Cell culture
MNT-1 (kindly provided by Dr. Vincent J. Hearing (Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA) (42), LLC-MK2 (Dainippon Pharma, Osaka, Japan), and Vero E6 (kindly provided by the Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan) cells were used in this study. MNT-1 cells were cultured in DMEM (Sigma-Aldrich, St Louis, MO, USA), whereas LLC-MK2 and Vero E6 cells were cultured in Eagle's MEM (Sigma-Aldrich). All media were supplemented with 10% FBS (Thermo Fisher Scientific, Waltham, MA, USA), 100 units/mL penicillin G and 100 mg/mL streptomycin. Cells were subcultured in 96-well plates (Greiner Bio-one, Baden-W€ urttemberg, Germany) for experiments. Before specimen inoculation, media were changed to DMEM or MEM without FBS and supplemented with trypsin (Sigma-Aldrich) at 2 mg/mL (Vero and Vero E6), 5 mg/mL (MNT-1) or 10 mg/mL (LLC-MK2).
Viruses
Five strains of HMPV were used in this study: Sendai-H/ 517/2015 (genetic lineage A2), a clinical isolate that had been passaged four times in MNT-1 cells, and four prototype strains, NL/1/00 (genetic lineage A1), which had been passaged five times in tMK and once in Vero-118 cells, NL/17/00 (genetic lineage A2), which had been passaged three times in Vero-118 cells, NL/1/99 (genetic lineage B1), which had been passaged five times in tMK and once in Vero-118 cells, and NL/1/94 (genetic lineage B2), which had been passaged four times in Vero-118 cells (a kind gift from Professor Eric Claassen, ViroNovative BV, Rotterdam, the Netherlands).
Clinical specimens and virus isolation
From January 2003 to December 2016, a total of 36755 nasal swab, nasal aspirate and throat swab samples were collected from patients with respiratory infections in the Sendai City area for virus isolation using the tissue culture microplate method (39) (40) (41) . Briefly, specimens were collected in 3 mL of transport medium (MEM with 0.5% gelatin containing 500 units/mL penicillin G and 500 mg/mL streptomycin), followed by low-speed (1710 Â g) centrifugation at 4°C for 15 min. The supernatant was inoculated into 96-well microplates containing six cell lines: HFL-III, HEp-2, Vero or Vero E6, MDCK, LLC-MK2 and HMV-II (used before October 2013) or MNT-I (which was used instead of HMV-II from October 2013). After inoculation, the plates were centrifuged at 400 Â g for 30 min at room temperature and the cells maintained at 33°C in a 5% CO 2 atmosphere without passage or medium change until 4 weeks post-inoculation. Cultures were then examined for CPE twice a week. Isolation of HMPV by RT-PCR was confirmed using specific primers (43) .
Infectivity titration
Viral titers in the culture medium were analyzed by TCID 50 endpoint assay. Briefly, confluent cell monolayers in 96-well microplates were inoculated with the virus and the supernatants harvested 12 days later. Each supernatant sample was serially diluted tenfold. Cells in microplates were then inoculated with 50 mL of each serial dilution for titration, centrifuged at 400 Â g for 30 min at room temperature and then incubated for 10 days at 33°C in a 5% CO 2 atmosphere to induce a CPE. Infectivity titers were calculated by Reed and Muench's method and expressed as TCID 50 / mL (44) .
Virus adsorption assay
Virus attachment was compared between cell lines by virus adsorption assay using a qRT-PCR protocol modified from Liu et al. (45) . Cultures of various cell concentrations in 96-well and 12-well plates were inoculated with HMPV (1 Â 10 8 copies per well), incubated at 4°C for 1 hr and then washed five times with DMEM to remove unbound virus. Total RNA, including viral RNA bound to cell surfaces, was extracted from the well and viral RNA quantified by real-time RT-PCR as detailed below using previously reported primers and probes (46) .
Extraction of RNA and RT-PCR
Viral RNA was extracted from clinical specimens (140 mL) using a QIAamp viral RNA Mini Kit (Qiagen, Venlo, the Netherlands) and total RNA from cell lysate (350 mL) for viral adsorption assay using an RNeasy Mini Kit (Qiagen). Isolated RNA was subjected to conventional RT-PCR, PCR-restriction fragment length polymorphisms and realtime RT-PCR as follows. The HMPV F protein gene was amplified using a PrimeScript One Step RT-PCR Kit Ver.2 (Takara Bio, Kusatsu, Shiga, Japan) following the method of Kaida et al. (43) . The PCR products were separated on 2% agarose gels and visualized by staining with ethidium bromide. Subgroups of isolated HMPV strains were distinguished by PCR-restriction fragment length polymorphisms (47) or sequencing of the viral F gene. Copy numbers of the viral N gene in clinical specimens and cell lysates were quantified by real-time RT-PCR. Briefly, cDNA was synthesized from viral and total RNA using High Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Foster, CA, USA) according to the manufacturer's instructions. The HMPV N gene was amplified by primers and TaqMan probe as described by Mackay et al. (46) using IQ Supermix (Bio-Rad, Hercules, CA, USA). The N gene copy number in the original specimen was calculated using a standard curve with cDNA generated from in vitro transcribed RNA amplified from the plasmid into which the target site was cloned (a kind gift from Stress Signal Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Osaka, Japan). Data were analyzed using MiniOpticon real-time PCR detection system CFX Manager software (Bio-Rad).
Statistical analysis
Data were analyzed using JMP Pro 11. 2. 0 software (SAS Institute Japan, Tokyo, Japan). Group differences were assessed by Kaplan-Meier log-rank test or anova with post hoc Tukey-Kramer tests. A P value less than 0.05 was considered to denote significance in all tests.
RESULTS
Appearance of CPE and viral growth kinetics in MNT-1 cells
First, we compared CPE characteristics after HMPV infection in MNT-1, LLC-MK2 and Vero E6 cells. Cells were inoculated with the clinical specimens from which the Sendai-H/517/2015 strain had originally been isolated, the specimens having been stored at À80°C since this initial analysis. The inoculated viral load was 5.0 Â 10 5 copies. All lines were monitored every day for CPEs. The CPE, as indicated by syncytium formation, first appeared in MNT-1 cells 5 days after inoculation, whereas we detected no evidence of pathology in LLC-MK2 and Vero E6 cells (Fig. 1a left panels) . More than 10 days after inoculation, LLC-MK2 and Vero E6 cells exhibited only subtle CPEs, as indicated by sparse syncytium formation and cell granulation, respectively (Fig. 1a right panels) . We then compared viral growth in these cell lines using culture supernatants as described for the TCID 50 endpoint assay and found that viral growth was also greatest in MNT-1 cells (Fig. 1b) .
Next, we examined whether MNT-1 cells are also susceptible to other HMPV strains. Indeed, we found that MNT-1 cultures infected with 1 Â 10 5 TCID 50 of the prototype strains NL/1/00, NL/17/00, NL/1/99 and NL/1/94 all exhibited syncytium formation. In addition, LLC-MK2 cells exhibited syncytium formation, whereas Vero E6 showed granulation in response to all strains (Fig. 1c) . (Fig. 2a) . Vero E6 is also reportedly useful for HMPV isolation (7, 38) . We therefore compared efficiency of isolation in MNT-1, LLC-MK2 and Vero E6 cells using 25 randomly selected clinical specimens collected in 2014-2015 and since stored at À80°C, all having been confirmed positive for HMPVs by RT-PCR. At 4 weeks after inoculation, isolation frequency was 15/25 (60%) using LLC-MK2 cells, 17/25 (68%) using Vero 6 cells and 20/25 (80%) using MNT-1 cells. However, within 1 week of inoculation, frequency of isolation was markedly higher using MNT-1 cells (11/25, 44%) than LLC-MK2 (5/25, 20%) or Vero E6 cells (4/25, 16%) (Fig. 2b) , indicating the superiority of MNT-1 cells for HMPV isolation.
Basis of MNT-1 superiority for HMPV isolation
To elucidate why MNT-1 cells are superior for HMPV isolation, we first investigated whether the minimum viral copy number required for CPE detection in clinical specimens is lower than in other cell lines. We used realtime RT-PCR to measure and compare HMPV genome copy numbers in stored (À80°C) clinical specimens from which virus isolation could only be achieved using MNT-1 or LLC-MK2. We did not assess Vero E6 cells using this assay because we did not exclusively isolate HMPV in this cell line after the introduction of MNT-1 cells. We found no difference in minimum copy number among specimens from which isolation was possible using only MNT-1 or LLC-MK2 (Fig. 3a) , suggesting that MNT-1 is not more sensitive than LLC-MK2 (i.e., does not have a lower minimum copy number) for virus isolation. Furthermore, the minimum copy numbers of HMPV genome isolated by the cell cultures were (Fig. 3b) . These results suggest that the superiority of MNT-1 is probably not attributable to greater virus attachment to cellular receptors, but rather may be attributable to better growth efficiency and an earlier and more clear CPE.
Improved HMPV isolation using MNT-1
Since we first isolated HMPV using LLC-MK2 cells (48), we have successfully isolated all sublineages except A1, which has never been detected in Japan and has very rarely been isolated worldwide (7, 17, 23, 49, 50) . However, the number of HMPV isolations was far smaller (80/31154, 0.25%) than with tested specimen numbers. This situation did not change when we adopted Vero E6 cells between November 2005 and May 2010 (Fig. 4) . We then replaced HMV-II cells with MNT-1 cells for efficient isolation of HPIV (41); since then, the frequency of HMPV isolation has improved tenfold (102/4108, 2.5%) (Fig. 4) .
HMPV has been reported to cause epidemics mainly during the winter and spring months in temperate climates (2, 3, 7, 13-19); however, infections have been reported throughout the year (16, 17, 20) . Furthermore, co-circulation of HMPV subgroups has been reported in certain areas (7, (51) (52) (53) (54) . With our new isolation system using MNT-1, we were able to isolate HMPV in spring and early summer of 2014 and from winter to spring of 2015 and 2016, and to detect co-circulation of two sublineages in 2014 and three in 2016 (Fig. 4) .
Analyses of isolation-negative specimens
After introduction of MNT-1 cells, HMPV surveillance based on virus isolation has improved. The total isolation rate between October 2013 and December 2016 was 2.5% (102/4108) (Fig. 4) . However, this is still lower than the detection rates reported using RT-PCR-based surveillance (3.5%-9%) (21, 24, 29) . To check how many positive samples we were missing, we conducted genetic testing of 50 isolation-negative samples collected during peak periods of HMPV epidemics in 2014 and 2015. We found that 11 specimens were positive for a HMPV gene by nested RT-PCR, whereas only four of these 11 specimens were positive using real-time RT-PCR with copy numbers as low as 1 Â 10 2À3 copies/mL. The sensitivity of nested RT-PCR was comparable to that of real-time RT-PCR (data not shown), suggesting a high false-positive rate using nested RT-PCR and low falsenegative rate using MNT-1 cells (less than 10%), further implying that live virus counts in these false-negative specimens may be very low.
DISCUSSION
Isolation of live viruses is indispensable for investigating antigenic variation among epidemic strains and for immunological analyses of host reactions. Virus isolation using cell culture systems is less expensive than genetic screening using RT-PCR more easily screens a large number of clinical specimens. Therefore, virus isolation remains indispensable for clinical virology. In this study, we demonstrated the efficient detection of multiple strains of HMPV, a species difficult to detect by other culture systems, using MNT-1 cells.
Abiko et al. reported that the Vero E6 cell line is also useful for HMPV isolation because monolayers can remain confluent for 1 month without passage or medium change, allowing for incubation times of several weeks for a CPE to develop. However, efficiency of isolation was not significantly different from that achieved with LLC-MK2 (7). We have also used Vero E6 cells in the past without greatly improving isolation efficiency over that achieved with LLC-MK2 cells (Fig. 4) . Similarly, in this study the efficiency of isolation did not differ significantly between Vero E6 and LLC-MK2 cells, whereas it was substantially higher using MNT-1 cells (Fig. 2a, b) . Despite this greater efficiency of isolation, MNT-1 cells did not differ from LLC-MK2 cells in minimum copy number required for CPE appearance (both about 1 Â 10 2 copies/mL) ( Fig. 3a ) and similar to the 1.25 Â 10 2 copies/mL required for Vero E6 cells (38) . However, MNT-1 cells are superior because a clear CPE occurs earlier, which greatly reduces the labor required for virus isolation.
Efficient infection by HMPV in vitro reportedly depends on binding to cell surface glycosaminoglycans and avb1 integrin (55) (56) (57) (58) (59) . In our study, the viral load adsorbed by MNT-1 cells was no higher than that adsorbed by Vero E6 cells (Fig. 3b) , suggesting that expression of these putative receptors is not substantially stronger in MNT-1 cells. The cell surface protein a5b1 integrin is not a cellular receptor for HMPV but is reportedly essential for cell-cell fusion and effective propagation of HMPV infection (60) , as well as an important effector of the metastatic behavior of melanoma cells (61) (62) (63) (64) . In this study, MNT-1 exhibited clear syncytium formation following infection by all HMPV strains tested, whereas Vero E6 exhibited a more subtle CPE that was characterized by mild and delayed granular formation but no cell-cell fusion (Fig. 1 ). An important future challenge is to investigate the mechanisms underlying the superiority of MNT-1 cells for HMPV propagation.
In our trial comparing viral detection by isolation and RT-PCR, we were unable to isolate the virus from a few specimens, possibly because of small copy numbers. In contrast, many specimens found positive by nested RT-PCR were negative by real-time RT-PCR. Nested RT-PCR sometimes showed non-specific reactions, suggesting that there is a high risk of false-positives, whereas real-time RT-PCR is more specific and reliable than the former with comparable sensitivity. In addition, co-detection of human adenovirus, bocavirus and/or rhinovirus with HMPV (54.3%) using RT-PCR has frequently been reported (29) , suggesting that HMPV may not have been the true causative agent of the illnesses of the infected patients. It may therefore be necessary to reevaluate claims that HMPV is the causative agent of an illness on the basis of frequent detection of the virus, particularly when data have been obtained only by nested RT-PCR.
In summary, we have here demonstrated that the MNT-1 cell line can be used for the efficient isolation of HMPV as a result of clear and timely expression of a CPE. Thus, MNT-1 cells have the potential to enhance our understanding of HMPV pathogenesis and epidemiology. 
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